US Stock MarketDetailed Quotes

Orchestra BioMed (OBIO)

Watchlist
  • 3.970
  • -0.020-0.50%
Close May 1 15:59 ET
  • 3.970
  • 0.0000.00%
Post 16:10 ET
237.73MMarket Cap-3.58P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Orchestra BioMed (OBIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
1,169.22%33.48M
12,120.16%30.92M
-12.77%861K
7.46%836K
40.00%868K
-4.42%2.64M
-3.44%253K
135.56%987K
-14.97%778K
-46.74%620K
Operating revenue
1,169.22%33.48M
12,120.16%30.92M
-12.77%861K
7.46%836K
40.00%868K
-4.42%2.64M
-3.44%253K
135.56%987K
-14.97%778K
-46.74%620K
Cost of revenue
-6.86%190K
-12.07%51K
-27.94%49K
4.55%46K
29.41%44K
9.68%204K
23.40%58K
65.85%68K
-18.52%44K
-22.73%34K
Gross profit
1,267.79%33.29M
15,728.72%30.87M
-11.64%812K
7.63%790K
40.61%824K
-5.44%2.43M
-9.30%195K
143.12%919K
-14.75%734K
-47.68%586K
Operating expense
27.52%85.1M
42.91%24.11M
22.39%21.13M
14.35%20.12M
31.55%19.75M
23.40%66.74M
32.89%16.87M
15.83%17.26M
27.33%17.59M
18.51%15.01M
Selling and administrative expenses
12.47%26.91M
23.52%7.29M
25.27%7.1M
-3.14%6.26M
6.21%6.26M
18.13%23.93M
41.00%5.9M
-10.69%5.67M
21.61%6.47M
33.69%5.9M
Research and development costs
35.93%58.19M
53.34%16.82M
20.97%14.03M
24.51%13.85M
47.96%13.48M
26.56%42.8M
28.90%10.97M
35.49%11.6M
30.91%11.13M
10.39%9.11M
Operating profit
19.43%-51.81M
140.50%6.75M
-24.30%-20.31M
-14.64%-19.33M
-31.19%-18.92M
-24.84%-64.3M
-33.62%-16.68M
-12.52%-16.34M
-30.13%-16.86M
-24.93%-14.42M
Net non-operating interest income expense
-134.21%-1.15M
-246.17%-763K
-156.22%-515K
-103.99%-36K
-83.66%166K
-12.81%3.36M
-52.89%522K
0.11%916K
-4.14%902K
14.80%1.02M
Non-operating interest income
----
----
----
----
-83.66%166K
-12.81%3.36M
-52.89%522K
0.11%916K
-4.14%902K
14.80%1.02M
Non-operating interest expense
--1.15M
----
----
----
----
----
----
----
----
----
Total other finance cost
----
----
156.22%515K
103.99%36K
----
----
----
---916K
---902K
----
Other net income (expense)
421.52%254K
94.60%-79K
0
25.81%-23K
80.00%-56K
Gain on sale of security
473.53%254K
----
----
----
----
78.21%-68K
--0
----
25.81%-23K
83.93%-45K
Special income (charges)
----
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
----
----
----
----
----
---11K
--0
----
----
---11K
Income before tax
13.64%-52.7M
138.66%6.25M
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
Income tax
Net income
13.64%-52.7M
138.66%6.25M
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
Net income continuous Operations
13.64%-52.7M
138.66%6.25M
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
Minority interest income
Net income attributable to the parent company
13.64%-52.7M
138.66%6.25M
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
Preferred stock dividends
254K
Other preferred stock dividends
Net income attributable to common stockholders
13.22%-52.96M
137.08%5.99M
-35.02%-20.83M
-21.17%-19.36M
-39.31%-18.76M
-24.23%-61.02M
-26.03%-16.16M
-15.85%-15.43M
-32.66%-15.98M
-23.06%-13.46M
Basic earnings per share
33.13%-1.11
160.47%0.26
2.44%-0.4
-11.11%-0.5
-28.95%-0.49
-12.16%-1.66
-16.22%-0.43
-7.89%-0.41
-28.57%-0.45
5.00%-0.38
Diluted earnings per share
33.13%-1.11
160.47%0.26
2.44%-0.4
-11.11%-0.5
-28.95%-0.49
-12.16%-1.66
-16.22%-0.43
-7.89%-0.41
-28.57%-0.45
5.00%-0.38
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 1,169.22%33.48M12,120.16%30.92M-12.77%861K7.46%836K40.00%868K-4.42%2.64M-3.44%253K135.56%987K-14.97%778K-46.74%620K
Operating revenue 1,169.22%33.48M12,120.16%30.92M-12.77%861K7.46%836K40.00%868K-4.42%2.64M-3.44%253K135.56%987K-14.97%778K-46.74%620K
Cost of revenue -6.86%190K-12.07%51K-27.94%49K4.55%46K29.41%44K9.68%204K23.40%58K65.85%68K-18.52%44K-22.73%34K
Gross profit 1,267.79%33.29M15,728.72%30.87M-11.64%812K7.63%790K40.61%824K-5.44%2.43M-9.30%195K143.12%919K-14.75%734K-47.68%586K
Operating expense 27.52%85.1M42.91%24.11M22.39%21.13M14.35%20.12M31.55%19.75M23.40%66.74M32.89%16.87M15.83%17.26M27.33%17.59M18.51%15.01M
Selling and administrative expenses 12.47%26.91M23.52%7.29M25.27%7.1M-3.14%6.26M6.21%6.26M18.13%23.93M41.00%5.9M-10.69%5.67M21.61%6.47M33.69%5.9M
Research and development costs 35.93%58.19M53.34%16.82M20.97%14.03M24.51%13.85M47.96%13.48M26.56%42.8M28.90%10.97M35.49%11.6M30.91%11.13M10.39%9.11M
Operating profit 19.43%-51.81M140.50%6.75M-24.30%-20.31M-14.64%-19.33M-31.19%-18.92M-24.84%-64.3M-33.62%-16.68M-12.52%-16.34M-30.13%-16.86M-24.93%-14.42M
Net non-operating interest income expense -134.21%-1.15M-246.17%-763K-156.22%-515K-103.99%-36K-83.66%166K-12.81%3.36M-52.89%522K0.11%916K-4.14%902K14.80%1.02M
Non-operating interest income -----------------83.66%166K-12.81%3.36M-52.89%522K0.11%916K-4.14%902K14.80%1.02M
Non-operating interest expense --1.15M------------------------------------
Total other finance cost --------156.22%515K103.99%36K---------------916K---902K----
Other net income (expense) 421.52%254K94.60%-79K025.81%-23K80.00%-56K
Gain on sale of security 473.53%254K----------------78.21%-68K--0----25.81%-23K83.93%-45K
Special income (charges) ----------------------0----------------
Other non- operating income (expenses) -----------------------11K--0-----------11K
Income before tax 13.64%-52.7M138.66%6.25M-35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M-23.06%-13.46M
Income tax
Net income 13.64%-52.7M138.66%6.25M-35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M-23.06%-13.46M
Net income continuous Operations 13.64%-52.7M138.66%6.25M-35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M-23.06%-13.46M
Minority interest income
Net income attributable to the parent company 13.64%-52.7M138.66%6.25M-35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M-23.06%-13.46M
Preferred stock dividends 254K
Other preferred stock dividends
Net income attributable to common stockholders 13.22%-52.96M137.08%5.99M-35.02%-20.83M-21.17%-19.36M-39.31%-18.76M-24.23%-61.02M-26.03%-16.16M-15.85%-15.43M-32.66%-15.98M-23.06%-13.46M
Basic earnings per share 33.13%-1.11160.47%0.262.44%-0.4-11.11%-0.5-28.95%-0.49-12.16%-1.66-16.22%-0.43-7.89%-0.41-28.57%-0.455.00%-0.38
Diluted earnings per share 33.13%-1.11160.47%0.262.44%-0.4-11.11%-0.5-28.95%-0.49-12.16%-1.66-16.22%-0.43-7.89%-0.41-28.57%-0.455.00%-0.38
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -